News

The diversified sources of the somatic cells call for additional oversight to prevent the introduction, transmission, and spread of communicable disease.

Transaction with special purpose acquisition company totals $138 million.

The latest industry happenings, all in one place.

RWE can augment, extend, or enrich the findings from clinical trials to provide valuable evidence to support the development programs for product approvals.